Volume 60, Issue 8 pp. 1700-1712
TRANSFUSION PRACTICE

Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States

Ruchika Goel

Ruchika Goel

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Mississippi Valley Regional Blood Center, and Simmons Cancer Institute at SIU SOM, Springfield, Illinois, USA

Search for more papers by this author
Cassandra D. Josephson

Cassandra D. Josephson

Department of Pathology, Center for Transfusion and Cellular Therapies, Emory University School of Medicine and Childrenʼs Healthcare of Atlanta, Atlanta, Georgia, USA

Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service, Emory University School of Medicine and Childrenʼs Healthcare of Atlanta, Atlanta, Georgia, USA

Search for more papers by this author
Eshan U. Patel

Eshan U. Patel

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Molly R. Petersen

Molly R. Petersen

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Zoe Packman

Zoe Packman

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Eric Gehrie

Eric Gehrie

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Evan M. Bloch

Evan M. Bloch

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Parvez Lokhandwala

Parvez Lokhandwala

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Paul M. Ness

Paul M. Ness

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Search for more papers by this author
Louis Katz

Louis Katz

Mississippi Valley Regional Blood Center, Davenport, Iowa, USA

Search for more papers by this author
Marianne Nellis

Marianne Nellis

Department of Pediatrics, New York Presbyterian Hospital – Weill Cornell Medicine, New York, New York, USA

Search for more papers by this author
Oliver Karam

Oliver Karam

Department of Pediatrics, Childrenʼs Hospital of Richmond at VCU, Richmond, Virginia, USA

Search for more papers by this author
Aaron A. R. Tobian

Corresponding Author

Aaron A. R. Tobian

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA

Address reprint requests to: Dr. Aaron. A.R. Tobian MD PhD, Department of Pathology, Johns Hopkins University, Carnegie 437, 600 N. Wolfe St., Baltimore, MD 21287; e-mail: [email protected]Search for more papers by this author
First published: 26 June 2020
Citations: 19

This work was supported in part by the National Institutes of Health (R01AI120938 and R01AI128779 to A.A.R.T., T32AI102623 to E.U.P., and K23HL151826 to E.M.B.).

Abstract

BACKGROUND

Factors associated with red blood cell (RBC), plasma, and platelet transfusions in hospitalized neonates and children across the United States have not been well characterized.

METHODS

Data from the Kids’ Inpatient Database (KID) 2016 were analyzed. KID is a random sample of 10% of all uncomplicated in-hospital births and 80% of remaining pediatric discharges from approximately 4200 US hospitals. Sampling weights were applied to generate nationally representative estimates. Primary outcome was one or more RBC transfusion procedures; plasma and platelet transfusions were assessed as secondary outcomes. Analysis was stratified by age: neonates (NEO; ≤28 d), and nonneonates (PED; >28 d and <18 y). Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs).

RESULTS

Among 5,604,984 total hospitalizations, overall prevalence of transfusions was 1.07% (95% CI, 0.94%-1.22%) for RBCs, 0.17% (95% CIs, 0.15%-0.21%) for plasma and 0.35% (95% CI, 0.30%-0.40%) for platelet transfusions. RBC transfusions occurred among 0.43% NEO admissions and 2.63% PED admissions. For NEO admissions, RBC transfusion was positively associated with nonwhite race, longer length of hospitalization, highest risk of mortality (aOR, 86.58; 95% CI, 64.77-115.73) and urban teaching hospital location. In addition to the above factors, among PED admissions, RBC transfusion was positively associated with older age, female sex (aOR, 1.10; 95% CI, 1.07-1.13), and elective admission status (aOR, 1.62; 95% CI, 1.46-1.80). Factors associated with plasma and platelet transfusions were largely similar to those associated with RBC transfusion, except older age groups had lower odds of plasma transfusion among PED admissions.

CONCLUSIONS

While there is substantial variability in the proportion of neonates and nonneonatal children transfused nationally, there are several similar, yet unique, nonlaboratory predictors of transfusion identified in these age groups.

CONFLICT OF INTEREST

The authors have disclosed no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.